ClosedSuppliesEuropeanOnderhandeling zonder bekendmaking

Voluntary transparency regarding retrospective supply of tetravalent influenza vaccines

Rijksinstituut voor Volksgezondheid en Milieu (RIVM) · Onderhandeling zonder bekendmaking · 1 lots · 220383
Type
Supplies
33650000
Estimated value
Not published
To deadline
Ongoing
Knock-outs
n/a
exclusion grounds
Award basis
Best price-quality ratio
Assess manuallyconfidence low

The National Institute for Public Health and the Environment (RIVM), commissioned by the Ministry of Health, Welfare and Sport (VWS), has placed an emergency order for additional tetravalent influenza vaccines. It is expected that the corona pandemic will significantly increase the demand for influenza vaccination in the 2021/2022 season. The contract is subject to a negotiated procedure without publication, meaning the tender will not be made public. RIVM is seeking a reliable supplier capable of delivering the requested quantity within a short timeframe, meeting the necessary quality and safety standards. The focus is on rapid availability, price competitiveness, and a robust supply chain to support public health objectives.

Supplies · Onderhandeling zonder bekendmaking · European procedure

European
Contract type
Supplies
Onderhandeling zonder bekendmaking
Estimated value
Estimate not published
Submission deadline
Ongoing
Scope
European
European procedure
Lots
1
1 lots
Main CPV code
Location
Bilthoven
CharacteristicsCPV 33SuppliesEU tenderinfluenza vaccinetetravalentcorona

01What is being requested

The National Institute for Public Health and the Environment (RIVM), commissioned by the Ministry of Health, Welfare and Sport (VWS), has placed an emergency order for additional tetravalent influenza vaccines. It is expected that the corona pandemic will significantly increase the demand for influenza vaccination in the 2021/2022 season. The contract is subject to a negotiated procedure without publication, meaning the tender will not be made public. RIVM is seeking a reliable supplier capable of delivering the requested quantity within a short timeframe, meeting the necessary quality and safety standards. The focus is on rapid availability, price competitiveness, and a robust supply chain to support public health objectives.

The urgent procurement on behalf of VWS of additional tetravalent influenza vaccines, as it is expected that the demand for influenza vaccines will also increase sharply in the 2021/2022 season due to the corona epidemic.

33650000Supplies
1Lot 1

02Outcome

Awarded

Mylan Healthcare BV

03Exclusion grounds

Exclusion grounds — consult the ESPD
  • No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).

04Value in context

Estimate not published

The contracting authority did not publish an estimated value — common for a large share of contracts. The EU threshold for leveringen is € 221.000, for reference.

05Bidders in this segment

#Likely bidderFitWins
1GlaxoSmithKline B.V.SME79
2Mediost B.V.SME7714×
3Siemens Healthineers Nederland B.V.SME7713×
4Philips Nederland B.V.SME7615×
5Bilthoven Biologicals B.V.SME73
6Genzyme Europe B.VSME71

06Legal themes that may be relevant here

07Frequently asked questions

What is the reason for this contract?
The contract concerns the urgent procurement of additional tetravalent influenza vaccines. This is necessary because the demand for influenza vaccination is strongly expected to increase in the 2021/2022 season as a result of the corona epidemic.
What is the object of the supply?
It concerns the supply of additional tetravalent influenza vaccines for the 2021/2022 season.

Automatically compiled from the official tender data and documents.

08Estimated value versus the market

p25
€ 317K
median
€ 892K
p75
€ 3,3 mln
deze opdracht

Gegunde waarden in CPV 33 · leveringen n=528